
Buffett’s “follow me” signal just reversed
For years, Berkshire Hathaway has been the investing equivalent of the cool kid’s lunch table. If Buffett was in, plenty of people wanted a seat. So when Berkshire reportedly sold its entire UnitedHealth stake, it’s not exactly the kind of move UNH shareholders want to hear before coffee.
Why investors care
This isn’t just a housekeeping trade. A full exit from a blue-chip health insurer can read like a quiet vote of no confidence, even if Berkshire had its own portfolio reasons for heading for the door.
What matters for you:
- It puts fresh spotlight on UNH’s turnaround story and whether the market is still too optimistic
- It can fuel sentiment pressure in the near term, especially with Buffett’s name attached
- It reminds investors that big-money exits can matter almost as much as earnings beats
Big picture
UNH doesn’t suddenly stop being a giant because Berkshire sold. But in a market that loves to overanalyze every Buffett breadcrumb, this is one more clue that the smart-money crowd may be getting more selective. And when the legend leaves the room, everybody else checks their own seat.
